Pages that link to "Q44015331"
Jump to navigation
Jump to search
The following pages link to Human pharmacokinetics of the antiviral drug DHPG. (Q44015331):
Displaying 50 items.
- How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients (Q28069489) (← links)
- A rapid and sensitive method for the quantification of ganciclovir in plasma using liquid chromatography/selected reaction monitoring/mass spectrometry (Q30842651) (← links)
- The role of ganciclovir for the management of cytomegalovirus retinitis in HIV patients: Pharmacological review and update on new developments (Q33400808) (← links)
- Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer (Q33650105) (← links)
- Enhanced delivery of ganciclovir to the brain through the use of redox targeting (Q33753141) (← links)
- Mechanisms of transport of nucleosides and nucleoside analogues in choroid plexus (Q33933484) (← links)
- Monitoring of trough plasma ganciclovir levels and peripheral blood cytomegalovirus (CMV)-specific CD8+ T cells to predict CMV DNAemia clearance in preemptively treated allogeneic stem cell transplant recipients. (Q34057379) (← links)
- Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the (Q34212799) (← links)
- CNS manifestations of cytomegalovirus infections: diagnosis and treatment (Q34626898) (← links)
- Pharmacokinetics of ganciclovir and valganciclovir in the adult horse (Q34684840) (← links)
- Ganciclovir penetrates into the cerebrospinal fluid of an infant with congenital cytomegalovirus infection (Q35315818) (← links)
- Ganciclovir pharmacokinetics during renal impairment (Q35566078) (← links)
- Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis (Q35814373) (← links)
- Emerging therapies for herpes viral infections (types 1 - 8). (Q35967376) (← links)
- Ganciclovir and Foscarnet Therapy of Cytomegalovirus-Associated Meningoencephalitis in a Hemodialysis Patient With Liver Transplantation: Case Report (Q36056396) (← links)
- The antiviral drug ganciclovir does not inhibit microglial proliferation and activation (Q36134639) (← links)
- Evaluation of SQ 34,514: pharmacokinetics and efficacy in experimental herpesvirus infections in mice (Q36754271) (← links)
- Pharmacokinetics of ganciclovir during continuous venovenous hemodiafiltration in critically ill patients (Q37544453) (← links)
- Valganciclovir in adult solid organ transplant recipients: pharmacokinetic and pharmacodynamic characteristics and clinical interpretation of plasma concentration measurements. (Q37570464) (← links)
- Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events (Q37590851) (← links)
- CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency (Q37700176) (← links)
- Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections (Q37880547) (← links)
- Ganciclovir--a review of pharmacology, therapeutic efficacy and potential use for treatment of congenital cytomegalovirus infections (Q38305554) (← links)
- Therapeutic drug monitoring of anti-infective agents in critically ill patients (Q38790740) (← links)
- Cytomegalovirus encephalitis in two patients with AIDS receiving ganciclovir for cytomegalovirus retinitis. (Q39223379) (← links)
- Cell-based delivery of glucagon-like peptide-1 using encapsulated mesenchymal stem cells. (Q39277278) (← links)
- Cytomegalovirus ventriculoencephalitis after unrelated double cord blood stem cell transplantation with an alemtuzumab-containing preparative regimen for Philadelphia-positive acute lymphoblastic leukemia. (Q39773124) (← links)
- Drug interactions with zidovudine phosphorylation in vitro. (Q39779916) (← links)
- Population differences in ganciclovir clearance as determined by nonlinear mixed-effects modelling (Q39780677) (← links)
- Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group (Q39782822) (← links)
- Diagnosis of cytomegalovirus infections by shell vial assay and conventional cell culture during antiviral prophylaxis (Q40180848) (← links)
- Successful ganciclovir therapy in a patient with human herpesvirus-6 encephalitis after unrelated cord blood transplantation: usefulness of longitudinal measurements of viral load in cerebrospinal fluid (Q40274744) (← links)
- Ganciclovir. An update of its therapeutic use in cytomegalovirus infection (Q40395491) (← links)
- Treatment of alpha and beta herpesvirus infections in solid organ transplant recipients (Q40426465) (← links)
- Viral load and ganciclovir (GCV) concentration in cerebrospinal fluid of patients successfully treated with GCV or valGCV for human herpesvirus 6 encephalitis/myelitis following umbilical cord blood transplantation (Q40599474) (← links)
- Pharmacokinetics of anti-infective agents in paediatric patients (Q40686147) (← links)
- Comparative pharmacokinetics of antiviral nucleoside analogues (Q40886850) (← links)
- A sensitive and specific liquid-chromatographic assay for determination of ganciclovir in plasma and urine and its application to pharmacokinetic studies in the rabbit (Q41784974) (← links)
- A case of severe ganciclovir-induced encephalopathy (Q41857230) (← links)
- Pharmacokinetics of ganciclovir in renal transplant children (Q43710488) (← links)
- Cytomegalovirus ventriculoencephalitis in a bone marrow transplant recipient receiving antiviral maintenance: clinical and molecular evidence of drug resistance (Q43751129) (← links)
- Ganciclovir pharmacokinetics and cytokine dynamics in renal transplant recipients with cytomegalovirus infection (Q43778417) (← links)
- TRAIL enhances thymidine kinase/ganciclovir gene therapy of neuroblastoma cells (Q43963746) (← links)
- Ganciclovir-resistant cytomegalovirus encephalitis in a bone marrow transplant recipient. (Q44282953) (← links)
- Safety of alternating ganciclovir and foscarnet maintenance therapy in human immunodeficiency virus (HIV)-related cytomegalovirus infections. An open-labeled pilot study (Q45778365) (← links)
- Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene (Q45865909) (← links)
- Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis (Q46199542) (← links)
- Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice (Q48312954) (← links)
- Two cases of cytomegalovirus infection revealed by hearing loss in HIV-infected patients (Q50510849) (← links)
- A fatal case of cytomegalovirus ventriculoencephalitis in a mycosis fungoides patient who received multiple umbilical cord blood cell transplantations. (Q51366762) (← links)